Role of vascular endothelial growth factor A in children with acquired airway stenosis

Annals of Otology, Rhinology and Laryngology

Volumn 116, Issue 6, 2007, Pages 430-435

  Rahbar, Reza ^a   Brown, Lawrence F ^b   Folkman, Judah ^a   McGill, Trevor J ^a   Healy, Gerald B ^a   Liu, Guanmei ^b   Vargas, Sara O ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Airway stenosis; Angiogenesis; Vascular endothelial growth factor A

Indexed keywords

MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CHILD; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM HYPERPLASIA; FEMALE; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFANT; INTUBATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR FORMATION; SQUAMOUS EPITHELIUM; SUBGLOTTIC STENOSIS; WOUND HEALING;

EID: 34250832032     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940711600607     Document Type: Article

References (38)

1. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
2. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989;108:2477-82.
3. Scioscia KA, April MM, Miller F, Gruber BL. Growth factors in subglottic stenosis. Ann Otol Rhinol Laryngol 1996; 105:936-43.
4. Brown LF, Yeo K-T, Berse B, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176:1375-9.
5. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T. Colocalization of transforming growth factor-β2 with alpha 1(1) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990;86:917-22.
6. Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 1989;109: 903-14.
7. Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992;42:1457-61.
8. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993;53:4727-35.
9. Doolin EJ, Strande LF, Tsuno K, Santos MC. Pharmacologic inhibition of collagen in an experimental model of subglottic stenosis. Ann Otol Rhinol Laryngol 1998;107:275-9.
10. Rahbar R, Shapshay SM, Healy GB. Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol 2001;110:1-6.
11. Rahbar R, Jones DJ, Nuss RC, et al. The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: friend or foe? Arch Otolaryngol Head Neck Surg 2002;128:401-6.
12. Ingrams DR, Ashton P, Dhingra J, Shah R, Shapshay SM. Slow-release 5-fluorouracil and triamcinolone reduces subglottic stenosis in a rabbit model. Ann Otol Rhinol Laryngol 2000; 109:422-4.
13. Liu H, Chen JC, Holinger LD, Gonzalez-Crussi F. Histopathologic fundamentals of acquired laryngeal stenosis. Pediatr Pathol Lab Med 1995;15:655-77.
14. Fechner RE, Cooper PH, Mills SE. Pyogenic granuloma of the larynx and trachea. A causal and pathologic misnomer for granulation tissue. Arch Otolaryngol 1981;107:30-2.
15. Duynstee ML, de Krijger RR, Monnier P, Verwoerd CD, Verwoerd-Verhoef HL. Subglottic stenosis after endolaryngeal intubation in infants and children: result of wound healing processes. Int J Pediatr Otorhinolaryngol 2002;62:1-9.
16. Chen JC, Holinger LD. Acquired laryngeal lesions. Pathologic study using serial macrosections. Arch Otolaryngol Head Neck Surg 1995;121:537-43.
17. Gould SJ, Young M. Subglottic ulceration and healing following endotracheal intubation in the neonate: a morphometric study. Ann Otol Rhinol Laryngol 1992;101:815-20.
18. Quiney RE, Gould SJ. Subglottic stenosis: a clinicopathological study. Clin Otolaryngol Allied Sci 1985;10:315-27.
19. Kim HK, Bian H, Randall T, Garces A, Gerstenfeld LC, Einhorn TA. Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis. J Bone Miner Res 2004;19:2041-8.
20. Lin C, McGough R, Aswad B, Block JA, Terek R. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res 2004;22:1175-81.
21. Tahery MM, Lee DA. Review: pharmacologic control of wound healing in glaucoma filtration surgery. J Ocul Pharmacol 1989;5:155-79.
22. Reidenbach MM, Schmidt HM. Anatomical aspects of postintubational subglottic stenosis. Clin Anat 1995;8:273-80.
23. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97-132.
24. Rahbar R, Vargas SO, Folkman J, et al. Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005;114:289-95.
25. Brown LF, Guidi AJ, Schnitt SJ, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-56.
26. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-6.
27. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
28. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-4.
29. Bovee JV, van den Broek LJ, de Boer WI, Hogendoorn PC. Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis. J Pathol 1998;184:24-30.
30. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 1995;92:905-9.
31. Fava RA, Olsen NJ, Spencer-Green G, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994;180:341-6.
32. Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994;180:1141-6.
33. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor(vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-62.
34. Brown LF, Tognazzi K, Dvorak HF, Harrist TJ. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 1996;148:1065-74.
35. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
36. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993;90:8915-9.
37. Brown LF, Van de Water L, Harvey VS, Dvorak HF. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. Am J Pathol 1988;130:455-65.
38. Pokharel RP, Maeda K, Yamamoto T, et al. Expression of vascular endothelial growth factor in exuberant tracheal granulation tissue in children. J Pathol 1999;188:82-6.